SCHEMBL8435310

SCHEMBL8435310

CC(C)(C)OC(=O)N1CCC[C@H]1COc1ccc(Cl)nc1

nearest known ligand 0.61

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 4/20 0.61
CHRNA4 P43681 4/20 0.61
CHRNA3 P32297 3/20 0.61
CHRNB1 P11230 2/20 0.61
CHRNB4 P30926 2/20 0.61
CHRNB3 Q05901 2/20 0.61
ALOX5AP P20292 3/20 0.49
FEN1 P39748 1/20 0.49
CHRNA7 P36544 1/20 0.47
GPR119 Q8TDV5 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8437928 1.00 CHRNB2 (0.61) CHRNB2CHRNA4CHRNA3CHRNB1CHRNB4
SCHEMBL6588716 0.93 CHRNA3 (0.59) CHRNB2CHRNA4CHRNA3CHRNB1CHRNB4
SCHEMBL7472876 0.93 CHRNA3 (0.59) CHRNB2CHRNA4CHRNA3CHRNB1CHRNB4
SCHEMBL8436877 0.90 CHEK2 (0.51) CHRNB2CHRNA4CHRNA3CHRNB1CHRNB4
SCHEMBL7372804 0.88 CHRNB2 (0.60) CHRNB2CHRNA4CHRNA3CHRNB1CHRNB4
SCHEMBL7371666 0.88 CHRNB2 (0.60) CHRNB2CHRNA4CHRNA3CHRNB1CHRNB4
SCHEMBL18291353 0.87 ALOX5AP (0.57) CHRNB2CHRNA4CHRNA3CHRNB1CHRNB4
SCHEMBL7418829 0.87 ALOX5AP (0.53) CHRNB2CHRNA4CHRNA3CHRNB1CHRNB4
SCHEMBL18291345 0.87 ALOX5AP (0.57) CHRNB2CHRNA4CHRNA3CHRNB1CHRNB4
SCHEMBL2200111 0.86 ALOX5AP (0.57) ALOX5APGPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5948793-A 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling neurotransmitter release ABBOTT LABORATORIES (US) 1999-09-07 US disclosed
US-5914328-A CONTROL DOPAMINE RELEASE, ACTIVATE CHOLINERGIC CHANNELS ABBOTT LABORATORIES (US) 1999-06-22 US disclosed